Involvement of interleukin 2 receptors in conceptus-derived suppression of T and B cell proliferation in horses.

The research article investigates the manner in which an immunosuppressive factor derived from a horse fetus inhibits the proliferation or multiplication of lymphocytes, which are a category of white blood cells. In a nutshell, this factor seems to hinder the interaction of certain receptors on T lymphocytes, thereby indirectly slowing the multiplication of T and B lymphocytes.

Horse Conceptus-Derived Immunosuppressive Factor

• The immunosuppressive factor concerned with this study is derived from 20-day-old horse fetuses, and researchers obtained it from culture supernatants.
• It’s size is larger than 100,000 atomic mass units.
• The factor’s activity is measured by the reduced intake of a radioactive form of thymidine by lymphocytes that are stimulated by mitogens. Mitogens are substances that encourage cells to commence cell division.
• This inhibitory activity was found to be highest in cells stimulated by a specific mitogen derived from pokeweed.

Effect on Cell Proliferation

• Supplementing the cultures with this horse fetus-derived factor led to a reduction in the number of T cells in phytohaemagglutinin-stimulated cultures.
• The factor also suppressed the proliferation of both T and B cells in cultures stimulated by pokeweed mitogen.
• However, cell multiplication was found to be higher when the factor was added 24 hours or 48 hours after the initiation of cell stimulation.
• Once the horse fetus-derived factor was removed, the lymphocytes regained their full responsiveness.

Involvement of Interleukin 2 Receptors

• The research also involved exploring the function of Interleukin 2 (IL-2) receptors during the inhibitive effect of the horse fetus-derived factor on lymphocyte proliferation.
• The addition of recombinant IL-2 didn’t alter the immunosuppressive activity of the factor, but cell proliferation was found to be higher in cultures with added rIL-2.
• The results showed that the factor does not hinder the proliferation of IL-2-dependent murine cytolytic T lymphocyte cells.
• The data overall suggests that the factor suppresses T lymphocyte proliferation by inhibiting IL-2 receptor interaction in the early stages, which indirectly hampers B cell proliferation by interfering with T and B cell interactions.

Implications of the Study

• This strong immunosuppression capacity of the horse fetus-derived factor could potentially be one of the causes that prevent cell-mediated fetal allograft rejection during pregnancy.